• 1.

    Shapiro AMJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:13181330. doi: 10.1056/NEJMoa061267

  • 2.

    Vertex Pharmaceuticals. Vertex announces positive day 90 data for the first patient in the phase 1/2 clinical trial dosed with VX-880, a novel investigational stem cell-derived therapy for the treatment of type 1 diabetes. October 18, 2021. https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-positive-day-90-data-first-patient-phase-12

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    ClinicalTrials.gov. A safety, tolerability, and efficacy study of VX-880 in participants with type 1 diabetes. First posted: March 8, 2021; Last update posted: February 17, 2022. Identifier: NCT04786262. https://clinicaltrials.gov/ct2/show/NCT04786262

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Kolata, G. A cure for type 1 diabetes? For one man, it seems to have worked. The New York Times November 27, 2021. https://www.nytimes.com/2021/11/27/health/diabetes-cure-stem-cells.html

    • PubMed
    • Search Google Scholar
    • Export Citation

Pancreatic Islet Cell Transplantation: Are We Getting Closer?

Collin Jordan Collin Jordan, BS, is with the Division of Nephrology, Department of Medicine, Duke University School of Medicine, and Xunrong Luo, MD, PhD, is with the Division of Nephrology, Department of Medicine, and the Duke Transplant Center, Duke University School of Medicine, Durham, NC.

Search for other papers by Collin Jordan in
Current site
Google Scholar
PubMed
Close
and
Xunrong Luo Collin Jordan, BS, is with the Division of Nephrology, Department of Medicine, Duke University School of Medicine, and Xunrong Luo, MD, PhD, is with the Division of Nephrology, Department of Medicine, and the Duke Transplant Center, Duke University School of Medicine, Durham, NC.

Search for other papers by Xunrong Luo in
Current site
Google Scholar
PubMed
Close
Restricted access
Save